Real-time enrollment status for this biochemically recurrent prostate carcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:05 PM UTC
| NCT Number | NCT05054296 |
| Recruiting Status | Recruiting |
| Condition | Biochemically Recurrent Prostate Carcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 200 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | March 29, 2023 (Mar 29, 2023) |
As of July 13, 2026: Clinical trial NCT05054296 is currently recruiting participants. This clinical trial study for biochemically recurrent prostate carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05054296 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05054296 was last updated Mar 29, 2023 (March 29, 2023). HelloStudys verifies this status automatically.